Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair S Hall

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
American Journal of Hypertension|August 30, 2005
Renin-angiotensin system modulation: the weight of evidenceBen Brown, Alistair S Hall
Progress in Cardiovascular Diseases|November 21, 2015
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and DeathMartin H Strauss, Alistair S Hall
Heart (British Cardiac Society)|August 19, 2007
More about the "ARB MI paradox"Alistair S Hall, Martin H Strauss
Circulation|August 23, 2006
Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradoxMartin H Strauss, Alistair S Hall
Circulation|June 1, 2017
Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI ParadoxMartin H Strauss, Alistair S Hall
European Heart Journal|December 1, 2009
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART StudyMartin H Strauss, Alistair S Hall
Canadian Journal of Diabetes|December 27, 2017
The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes MellitusMartin H Strauss, Alistair S Hall
The New England Journal of Medicine|September 23, 2016
Blood-Pressure and Cholesterol Lowering in the HOPE-3 TrialMartin H Strauss, Alistair S Hall
Heart (British Cardiac Society)|March 25, 2018
Reaching the wrong conclusion: residual confounding by indicationJonathan A Batty, Alistair S Hall
BMC Cardiovascular Disorders|February 5, 2020
The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utilityRani Khatib, Nasrin Patel, Alistair S Hall
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
American Journal of Hypertension|August 30, 2005
Renin-angiotensin system modulation: the weight of evidenceBen Brown, Alistair S Hall
Progress in Cardiovascular Diseases|November 21, 2015
The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and DeathMartin H Strauss, Alistair S Hall
Heart (British Cardiac Society)|August 19, 2007
More about the "ARB MI paradox"Alistair S Hall, Martin H Strauss
Circulation|August 23, 2006
Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradoxMartin H Strauss, Alistair S Hall
Circulation|June 1, 2017
Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI ParadoxMartin H Strauss, Alistair S Hall
European Heart Journal|December 1, 2009
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART StudyMartin H Strauss, Alistair S Hall
Canadian Journal of Diabetes|December 27, 2017
The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes MellitusMartin H Strauss, Alistair S Hall
The New England Journal of Medicine|September 23, 2016
Blood-Pressure and Cholesterol Lowering in the HOPE-3 TrialMartin H Strauss, Alistair S Hall
Heart (British Cardiac Society)|March 25, 2018
Reaching the wrong conclusion: residual confounding by indicationJonathan A Batty, Alistair S Hall
BMC Cardiovascular Disorders|February 5, 2020
The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utilityRani Khatib, Nasrin Patel, Alistair S Hall
Pageof 14